000			03266nam a22004817a 4500
008			240723s20242024 xxu||||| |||| 00| 0 eng d
022			_a0887-6177
024			_a7633520 [pii]
040			_aOvid MEDLINE(R)
099			_a38520374
245			_aNeurocognitive Impairment in Post-COVID-19 Condition in Adults: Narrative Review of the Current Literature. [Review]
251			_aArchives of Clinical Neuropsychology. 39(3):276-289, 2024 Apr 24.
252			_aArch Clin Neuropsychol. 39(3):276-289, 2024 Apr 24.
253			_aArchives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists
260			_c2024
260			_p2024 Apr 24
260			_fFY2024
265			_sppublish
265			_tMEDLINE
520			_aThe severe acute respiratory syndrome coronavirus 2 virus has, up to the time of this article, resulted in >770 million cases of COVID-19 illness worldwide, and approximately 7 million deaths, including >1.1 million in the United States. Although defined as a respiratory virus, early in the pandemic, it became apparent that considerable numbers of people recovering from COVID-19 illness experienced persistence or new onset of multi-system health problems, including neurologic and cognitive and behavioral health concerns. Persistent multi-system health problems are defined as Post-COVID-19 Condition (PCC), Post-Acute Sequelae of COVID-19, or Long COVID. A significant number of those with PCC report cognitive problems. This paper reviews the current state of scientific knowledge on persisting cognitive symptoms in adults following COVID-19 illness. A brief history is provided of the emergence of concerns about persisting cognitive problems following COVID-19 illness and the definition of PCC. Methodologic factors that complicate clear understanding of PCC are reviewed. The review then examines research on patterns of cognitive impairment that have been found, factors that may contribute to increased risk, behavioral health variables, and interventions being used to ameliorate persisting symptoms. Finally, recommendations are made about ways neuropsychologists can improve the quality of existing research. Copyright © The Author(s) 2024. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: [email protected].
546			_aEnglish
650			_a*Cognitive Dysfunction
650			_a*COVID-19
650			_aAdult
650			_aCognitive Dysfunction/et [Etiology]
650			_aCOVID-19/co [Complications]
650			_aCOVID-19/px [Psychology]
650			_aHumans
650			_aSARS-CoV-2
650			_zAutomated
651			_aMedStar Good Samaritan Hospital
651			_aMedStar National Rehabilitation Network
657			_aJournal Article
657			_aReview
700			_aGarmoe, William _bMNRN
700			_aGorter, Bethany _bMNRN
700			_aKantor, Rachel _bMNRN
700			_aRao, Kavitha _bMGSH
790			_aGarmoe W, Rao K, Gorter B, Kantor R
856			_uhttps://dx.doi.org/10.1093/arclin/acae017 _zhttps://dx.doi.org/10.1093/arclin/acae017
858			_yGarmoe, William _uhttps://orcid.org/0009-0001-4350-9419 _zhttps://orcid.org/0009-0001-4350-9419
942			_cART _dArticle
999			_c14292 _d14292